Learn more about our company, latest developments in clinical diagnostics, and scientific breakthroughs in the rare disease field. Stay on top, subscribe to our newsletter and follow us on social media.
Supporting Patients for Accelerated Diagnosis and Treatment Development
Cambridge, MA USA & Rostock, Germany December...
Cambridge, MA USA & Rostock, Germany December 6, 2019 – CENTOGENE (Nasdaq: CNTG) today announced the expansion of its...
CAMBRIDGE, Mass. and ROSTOCK and BERLIN, Germany, November 21, 2019 (GLOBE NEWSWIRE) – CENTOGENE (Nasdaq: CNTG), a...
ROSTOCK/BERLIN, Deutschland und CAMBRIDGE, MA, USA 21. November 2019 (GLOBE NEWSWIRE) - CENTOGENE (Nasdaq: CNTG), ein...
Focus on Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
Accelerating new rare disease therapies through collaboration agreement
Global award honors entrepreneurship, innovation, and personal commitment
Supporting rare disease diagnosis, education, and clinical research
Driving Accelerated Diagnosis and Treatment Development
Driving personalized, immune-based therapy to target patients’ own immune responses
